Laparoscopic Cholecystectomy: An Evidence-based... Today

Laparoscopic Cholecystectomy: An Evidence-Based Evolution Laparoscopic cholecystectomy (LC) remains the for treating gallstone disease, a status solidified by its superior patient outcomes over traditional open surgery. As of 2026, evidence-based refinements continue to push the boundaries of this minimally invasive approach, focusing on safety protocols like the "Critical View of Safety" and the integration of robotic and magnetic technologies. The Gold Standard: Proven Benefits

Comprehensive meta-analyses involving millions of patients confirm that LC is significantly safer than open cholecystectomy. Key evidence-based advantages include: Laparoscopic Cholecystectomy: An Evidence-Based...

LC is associated with an 84% lower mortality rate and 54% fewer complications than open surgery. Key evidence-based advantages include: LC is associated with

Laparoscopic Cholecystectomy - StatPearls - NCBI Bookshelf - NIH Innovations in Technique and Technology

Patients typically stay in the hospital for 1.2 days compared to 6.4 days for open procedures, allowing a much quicker return to daily activities.

While the standard four-port technique is common, newer variations aim to further minimize invasiveness:

Clinical data show LC results in lower postoperative levels of inflammatory markers like C-reactive protein (CRP), leading to less surgical trauma. Innovations in Technique and Technology